Abstract:Women undergoing active surveillance for CIN2 in Denmark differed from women undergoing LLETZ with respect to several clinical characteristics. These differences can be explained by changes in the clinical management of CIN2 and the implementation of the HPV vaccine. Introduction Active surveillance for cervical intraepithelial neoplasia grade 2 (CIN2) has been implemented recently in many countries, including the Nordic countries. In Denmark, the only eligibility criterion for active surveillance for CIN2 is that the woman should be of reproductive age. With this study, we aimed to evaluate clinical and socioeconomic characteristics in women with CIN2 managed by active surveillance or large loop excision of the transformation zone (LLETZ) and to evaluate temporal changes in the clinical management of CIN2. Material and Methods We conducted a Danish nationwide study using data from healthcare registries. All female residents aged 18–40 years, diagnosed with incident CIN2 from January 1, 1998, to February 29, 2020, were included. We collected data on age, index cytology result, year of CIN2 diagnosis, region of residence, civil status, HPV vaccination status, and socioeconomic position indicators. The variables were tabulated overall and by management group (active surveillance vs. LLETZ). To evaluate time trends, we used joinpoint regression to calculate the annual percentage change (APC), including 95% confidence intervals (CI). Results Of the 27 536 women with CIN2 included, 12 500 (45.4%) underwent active surveillance, and 15 036 (54.6%) underwent a LLETZ. Women undergoing active surveillance were younger, more often HPV‐vaccinated, and more likely to have a normal/low‐grade index cytology result than women undergoing LLETZ. Socioeconomic position indicators did not differ. Over time, the proportion of women undergoing active surveillance increased from 21.7% in 2004 to 73.6% in 2019 (APC 9.7, 95% CI 8.1–11.4). The proportion of women undergoing active surveillance aged <30 declined over time (APC −2.2, 95% CI −2.9 to −1.5). The proportion of women with normal/low‐grade index cytology increased slightly to 51.6% in 2019 (APC 0.8, 95% CI 0.4–1.3). Conclusions The use of active surveillance for CIN2 has increased over the past two decades in Denmark. Observed differences in characteristics between women undergoing active surveillance versus LLETZ are likely related to indications for clinical management.

Exploring the trend of increased cervical intraepithelial neoplasia detection rates in the Netherlands

Time trends in the clinical management of cervical intraepithelial neoplasia grade 2: A Danish register‐based study

Recent increase in incidence of cervical precancerous lesions in Norway: Nationwide study from 1992 to 2016

Long-term trends in incidence, characteristics and prognosis of screen-detected and interval cancers in women participating in the Dutch breast cancer screening programme

Colposcopy referral and CIN3+ risk of human papillomavirus genotyping strategies in cervical cancer screening

Comparing SurePath, ThinPrep, and conventional cytology as primary test method: SurePath is associated with increased CIN II+ detection rates

Cervical cancer incidence after normal cytological sample in routine screening using SurePath, ThinPrep, and conventional cytology: population based study

Population-Based Incidence Rates of Cervical Intraepithelial Neoplasia in the Human Papillomavirus Vaccine Era

Trends in incidence, treatment, and relative survival of colorectal cancer in the Netherlands between 2000 and 2021

[Detection Trend of Vaginal Intraepithelial Neoplasia Diagnosed by Colposcopy Guided Biopsy from 2013 to 2015].

Increased detection of high grade CIN, when using electrical impedance spectroscopy as an adjunct to routine colposcopy, is maintained when used across international boundaries: Prospective data from nine European countries

Prevalence of higher-grade dysplasia in persistently high-risk human papillomavirus positive, cytology negative women after introduction of the new cervical cancer screening in Germany

Trends in cervical cancer: A decade‑long analysis of incidence, survival and demographic disparities in a Northern Italian province

Emerging trends and hotspots in cervical intraepithelial neoplasia research from 2013 to 2023: A bibliometric analysis

Methylation Analysis to Detect CIN3+ in High-Risk Human Papillomavirus-Positive Self-Samples From the Population-Based Cervical Cancer Screening Program

Trends in epidemiology and primary treatment of anal squamous cell carcinoma in the Netherlands (1990-2021)

Divergent effects of switching from cytology to HPV-based screening in the Nordic countries

Women with a positive high-risk human papillomavirus (HPV) test remain at increased risk of HPV infection and cervical precancer ≥15 years later

The impact of loss to follow‐up in the Dutch organised HPV‐based cervical cancer screening programme

Cervical histology after routine ThinPrep or SurePath liquid-based cytology and computer-assisted reading in Denmark

Long-Term Impact of the Dutch Colorectal Cancer Screening Program on Cancer Incidence and Mortality-Model-Based Exploration of the Serrated Pathway